102 related articles for article (PubMed ID: 10849550)
1. Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
Darling D; Hughes C; Galea-Lauri J; Gäken J; Trayner ID; Kuiper M; Farzaneh F
Gene Ther; 2000 Jun; 7(11):914-23. PubMed ID: 10849550
[TBL] [Abstract][Full Text] [Related]
2. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
Chan LM; Coutelle C; Themis M
Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
[TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
4. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
Zhang B; Xia HQ; Cleghorn G; Gobe G; West M; Wei MQ
Gene Ther; 2001 Nov; 8(22):1745-51. PubMed ID: 11892843
[TBL] [Abstract][Full Text] [Related]
5. Purification of retrovirus particles using heparin affinity chromatography.
Segura MM; Kamen A; Garnier A
Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
[TBL] [Abstract][Full Text] [Related]
6. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
Segura MM; Kamen A; Trudel P; Garnier A
Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
[TBL] [Abstract][Full Text] [Related]
7. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
8. Rapid concentration and purification of retrovirus by flocculation with Polybrene.
Landázuri N; Gupta M; Le Doux JM
J Biotechnol; 2006 Oct; 125(4):529-39. PubMed ID: 16647154
[TBL] [Abstract][Full Text] [Related]
9. A simple and quick method to concentrate MSCV retrovirus.
Kanbe E; Zhang DE
Blood Cells Mol Dis; 2004; 33(1):64-7. PubMed ID: 15223013
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors.
Themis M; Forbes SJ; Chan L; Cooper RG; Etheridge CJ; Miller AD; Hodgson HJ; Coutelle C
Gene Ther; 1998 Sep; 5(9):1180-6. PubMed ID: 9930318
[TBL] [Abstract][Full Text] [Related]
11. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration.
Kinyanjui MW; Ramos-Barbón D; Villeneuve A; Fixman ED
J Immunol Methods; 2006 Jul; 314(1-2):80-9. PubMed ID: 16842814
[TBL] [Abstract][Full Text] [Related]
13. SDF-1alpha/CXCL12 enhances retroviral-mediated gene transfer into immature subsets of human and murine hematopoietic progenitor cells.
Tao W; Hangoc G; Cooper S; Broxmeyer HE
Gene Ther; 2004 Jan; 11(1):61-9. PubMed ID: 14681698
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of retrovirus-mediated gene transfer into hepatocellular carcinoma cells.
Tsujinoue H; Kuriyama S; Nakatani T; Yoshiji H; Akahane T; Toyokawa Y; Fukui H; Yoshimatsu T; Ikenaka K
Int J Oncol; 2001 Apr; 18(4):801-7. PubMed ID: 11251177
[TBL] [Abstract][Full Text] [Related]
16. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
Kondo T; Ikeda K; Matsuo K
Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
[TBL] [Abstract][Full Text] [Related]
17. Preloading potential of retroviral vectors is packaging cell clone dependent and centrifugation onto CH-296 ensures highest transduction efficiency.
Sondergaard CS; Haldrup C; Beer C; Andersen B; Kohn DB; Pedersen L
Hum Gene Ther; 2009 Apr; 20(4):337-49. PubMed ID: 19281432
[TBL] [Abstract][Full Text] [Related]
18. Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors.
Pizzato M; Merten OW; Blair ED; Takeuchi Y
Gene Ther; 2001 May; 8(10):737-45. PubMed ID: 11420637
[TBL] [Abstract][Full Text] [Related]
19. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
20. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
